1998
DOI: 10.1016/s0016-5085(98)85600-x
|View full text |Cite
|
Sign up to set email alerts
|

Molecular genetics of pancreatic cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2002
2002
2018
2018

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
1
0
0
Order By: Relevance
“…In the present study, 54% of pancreatic cancers were P53-positive and this is consistent with previous reports of 47% (Bold et al, 1999), 54% (Sinicrope et al, 1996) and 64% (Hu et al, 1998). Although immunohistochemistry does not distinguish between wild-type and mutated or inactivated forms of P53, it is generally accepted that accumulated P53 represents a mutated type (Hall and Lane, 1994).…”
Section: Molecular and Cellular Pathologysupporting
confidence: 93%
“…In the present study, 54% of pancreatic cancers were P53-positive and this is consistent with previous reports of 47% (Bold et al, 1999), 54% (Sinicrope et al, 1996) and 64% (Hu et al, 1998). Although immunohistochemistry does not distinguish between wild-type and mutated or inactivated forms of P53, it is generally accepted that accumulated P53 represents a mutated type (Hall and Lane, 1994).…”
Section: Molecular and Cellular Pathologysupporting
confidence: 93%